University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland
The James Cancer Hospital and Solove Research Institute, Columbus

U tijeku regrutacijaFaza 1/2

Od 16 do 75 godina · Oba spola · Ažurirano 10. ruj 2026. · NCT03104491

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Cincinnati Children's Hospital Medical Center, Cincinnati

U tijeku regrutacijaFaza 1

Od 18 godina i više · Oba spola · Ažurirano 1. ruj 2026. · NCT07586618

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Children's Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital Medical Center, Cincinnati
Rainbow Babies and Childrens Hospital, Cleveland
i još 3

U tijeku regrutacijaFaza 1/2

Do 22 godina · Oba spola · Ažurirano 25. kol 2026. · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Cincinnati Children's Hospital Medical Center, Cincinnati

U tijeku regrutacijaFaza 2

Od 7 do 25 godina · Oba spola · Ažurirano 19. kol 2026. · NCT05082519

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Children's Hospital Medical Center, Cincinnati

U tijeku regrutacijaOpažajna studija

1 Day – 17 Years · Oba spola · Ažurirano 14. kol 2026. · NCT06274788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Childrens Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital, Cincinnati
University Hospitals Case Medical Center, Cleveland
i još 3

U tijeku regrutacijaOpažajna studija

Sve dobne skupine · Oba spola · Ažurirano 6. srp 2026. · NCT01351545

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

Cincinnati Children's Hospital Medical Center, Cincinnati

U tijeku regrutacijaFaza 1/2

Do 21 godina · Oba spola · Ažurirano 3. lip 2026. · NCT04195347

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Nationwide Children's Hospital, Columbus
Ohio State University Comprehensive Cancer Center, Columbus

U tijeku regrutacijaFaza 1

Od 2 godina i više · Oba spola · Ažurirano 29. svi 2026. · NCT05418088

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Children's Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital Medical Center, Cincinnati

U tijeku regrutacijaOpažajna studija

Sve dobne skupine · Oba spola · Ažurirano 18. svi 2026. · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Cincinnati Children's Hospital Medical Center, Cincinnati
University of Cincinnati, Cincinnati
The Ohio State University, Columbus

U tijeku regrutacijaFaza 1

Od 13 godina i više · Oba spola · Ažurirano 5. svi 2026. · NCT04771572

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

Ohio State University Medical Center, Columbus

U tijeku regrutacijaFaza 1

Od 18 do 65 godina · Oba spola · Ažurirano 25. ožu 2026. · NCT03533816

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

The Ohio State University Comprehensive Cancer Center, Columbus

U tijeku regrutacijaFaza 1/2

Od 12 godina i više · Oba spola · Ažurirano 24. ožu 2026. · NCT04988555

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Cleveland Clinic Foundation, Cleveland

U tijeku regrutacijaFaza 2

Od 18 do 54 godina · Oba spola · Ažurirano 17. ožu 2026. · NCT06918431

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Cleveland Clinic, Cleveland

U tijeku regrutacijaFaza 1

Od 18 godina i više · Oba spola · Ažurirano 5. stu 2025. · NCT04260022

HPC Offered for PRESERVE Expansion

The Ohio State University Medical Center, Columbus

U tijeku regrutacijaOpažajna studija

Od 12 do 80 godina · Oba spola · Ažurirano 28. kol 2025. · NCT07145411

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Cincinnati Children's Hospital Medical Center, Cincinnati
Rainbow Babies, Cleveland
Nationwide Children's Hospital, Columbus

U tijeku regrutacijaFaza 1

Od 1 do 21 godina · Oba spola · Ažurirano 6. pro 2024. · NCT05476770

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.